Pharsight

Ozobax patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10610502 METACEL PHARMS LLC Oral baclofen solutions
Aug, 2039

(15 years from now)

Ozobax is owned by Metacel Pharms Llc.

Ozobax contains Baclofen.

Ozobax has a total of 1 drug patent out of which 0 drug patents have expired.

Ozobax was authorised for market use on 18 September, 2019.

Ozobax is available in solution;oral dosage forms.

Ozobax can be used as treatment of spasticity.

The generics of Ozobax are possible to be released after 30 August, 2039.

Drugs and Companies using BACLOFEN ingredient

Market Authorisation Date: 18 September, 2019

Treatment: Treatment of spasticity

Dosage: SOLUTION;ORAL

How can I launch a generic of OZOBAX before it's drug patent expiration?
More Information on Dosage

OZOBAX family patents

Family Patents